ANAFRANIL Side Effects

6599789-5 | Abnormal Behaviour, Aggression, Anxiety, Chest Discomfort, Convulsion, Dyspnoea, Fatigue, Hypertension
on Feb 18, 2010 Male patient from BRAZIL , 40 years of age, was diagnosed with depression (What is depression?) and was treated with Anafranil (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, aggression, anxiety (What is anxiety?), chest discomfort, convulsion, dyspnoea, fatigue, hypertension. Anafranil dosage: 1 Tablet Daily. During the same period patient was treated with TEGRETOL XR (200 Mg, Unk) (View Tegretol-xr Review and Tegretol-xr Label ), TEGRETOL XR (400 Mg, 1 Tablet Daily) (View Tegretol-xr Review and Tegretol-xr Label ).

6556810-8 | Asthenia, Eating Disorder, Hypokinesia, Hyponatraemia
Patient was taking Anafranil (View Usage). Patient had the following side effects: asthenia, eating disorder (What is eating disorder?), hypokinesia, hyponatraemia on Jan 18, 2010 from SPAIN Additional patient health information: Female patient , 83 years of age, was diagnosed with depression (What is depression?), hypertension and. Anafranil dosage: 25 Mg Daily. During the same period patient was treated with ESIDRIX (25 Mg Daily) (View Esidrix Review and Esidrix Label ), SERECOR (View Serecor Review and Serecor Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), TRIATEC (View Triatec Review and Triatec Label ). Patient was hospitalized.

6336881-4 | Confusional State, Depressed Level Of Consciousness
Adverse event was reported on Aug 20, 2009 by a Male patient taking Anafranil (View Usage) (Dosage: 25 Mg, Qid) was diagnosed with depression (What is depression?), polyneuropathy, liver transplant (What is liver transplant?) and. Location: SPAIN , 65 years of age, After Anafranil was administered, patient had the following side effects: confusional state, depressed level of consciousness. During the same period patient was treated with TEGRETOL (200 Mg, Bid) (View Tegretol Review and Tegretol Label ), OXYCODONE (10 Mg, Bid) (View Oxycodone Review and Oxycodone Label ), GABAPENTIN (400 Mg, Tid) (View Gabapentin Review and Gabapentin Label ), CELLCEPT (500 Mg, Qid) (View Cellcept Review and Cellcept Label ), OMEPRAZOL ^ACYFABRIK^ (20 Mg, Qd) (View Omeprazol ^acyfabrik^ Review and Omeprazol ^acyfabrik^ Label ). Patient was hospitalized.

5943621-7 | Faecal Vomiting, Gastrointestinal Hypomotility, Intestinal Obstruction
on Feb 17, 2006 Male patient from ITALY , 58 years of age, was treated with Anafranil (View Usage). Patient experienced the following unwanted or unexpected effects: faecal vomiting, gastrointestinal hypomotility, intestinal obstruction. Anafranil dosage: 2 Tablets/d. During the same period patient was treated with BACLOFEN (1 Df, Tid) (View Baclofen Review and Baclofen Label ), TIAPRIDAL (30 Drp, Tid) (View Tiapridal Review and Tiapridal Label ), THERALENE (10 Drops/d) (View Theralene Review and Theralene Label ), CLOPIXOL (50 Drp, Tid) (View Clopixol Review and Clopixol Label ), LEPTICUR (1 Df/d) (View Lepticur Review and Lepticur Label ), RIVOTRIL (20 Drp, Tid) (View Rivotril Review and Rivotril Label ), AMPHOTERICIN B (2 Tablets/d) (View Amphotericin B Review and Amphotericin B Label ), MOPRAL (1 Tablet/d) (View Mopral Review and Mopral Label ). Patient was hospitalized.


5594286-8 | Cardiac Failure, Cardiomyopathy, Chest Pain, Ejection Fraction Decreased, Electrocardiogram Abnormal, Joint Swelling
on Jan 15, 2008 Female patient from DENMARK , 39 years of age, was diagnosed with schizophrenia and was treated with Anafranil (View Usage). Patient had the following side effects: cardiac failure, cardiomyopathy (What is cardiomyopathy?), chest pain (What is chest pain?), ejection fraction decreased, electrocardiogram abnormal, joint swelling. Anafranil dosage: 75 Mg, Bid. During the same period patient was treated with TRUXAL (Unk, Prn) (View Truxal Review and Truxal Label ), LEPONEX (400 Mg, Qd) (View Leponex Review and Leponex Label ), MIANSERIN (View Mianserin Review and Mianserin Label ). Patient was hospitalized.

5501528-3 | Body Temperature Increased, Cardio-respiratory Arrest, Convulsion, Hyperpyrexia, Psychomotor Hyperactivity
Patient was taking Anafranil (View Usage). After Anafranil was administered, patient had the following side effects: body temperature increased, cardio-respiratory arrest, convulsion, hyperpyrexia, psychomotor hyperactivity on Oct 26, 2007 from JAPAN Additional patient health information: Male patient , 23 years of age, weighting 163.1 lb, was diagnosed with depression (What is depression?) and. Anafranil dosage: . During the same period patient was treated with LUDIOMIL (View Ludiomil Review and Ludiomil Label ), TRYPTANOL (View Tryptanol Review and Tryptanol Label ), AMOXAPINE (View Amoxapine Review and Amoxapine Label ), TOLEDOMIN (View Toledomin Review and Toledomin Label ).

5491519-3 | Body Temperature Increased, Cardio-respiratory Arrest, Convulsion, Hyperpyrexia, Psychomotor Hyperactivity
Adverse event was reported on Oct 17, 2007 by a Male patient taking Anafranil (View Usage) (Dosage: ) was diagnosed with depression (What is depression?) and. Location: JAPAN , 23 years of age, weighting 163.1 lb, Patient experienced the following unwanted or unexpected effects: body temperature increased, cardio-respiratory arrest, convulsion, hyperpyrexia, psychomotor hyperactivity. During the same period patient was treated with LUDIOMIL (View Ludiomil Review and Ludiomil Label ), TRYPTANOL /AUS/ (View Tryptanol /aus/ Review and Tryptanol /aus/ Label ), AMOXAPINE (View Amoxapine Review and Amoxapine Label ), TOLEDOMIN (View Toledomin Review and Toledomin Label ).

5247742-6 | Benign Prostatic Hyperplasia, Blood Glucose Increased, Blood Pressure Increased, Nephrolithiasis, Syncope
on Feb 14, 2007 Male patient from BRAZIL , 52 years of age, weighting 165.3 lb, was diagnosed with depression (What is depression?), blood pressure increased and was treated with Anafranil (View Usage). Patient had the following side effects: benign prostatic hyperplasia, blood glucose increased, blood pressure increased, nephrolithiasis, syncope. Anafranil dosage: 25 Mg/day. During the same period patient was treated with HYDROCHLOROTHIAZIDE (25 Mg) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

5223415-0 | Completed Suicide
on Nov 30, 2006 Female patient from UNITED STATES , 19 years of age, was treated with Anafranil (View Usage). After Anafranil was administered, patient had the following side effects: completed suicide. Anafranil dosage: Oral. During the same period patient was treated with ZIPRASIDONE HCL (Oral) (View Ziprasidone Hcl Review and Ziprasidone Hcl Label ), SERTRALINE (Oral) (View Sertraline Review and Sertraline Label ).

5223413-7 | Completed Suicide
Patient was taking Anafranil (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide on Nov 30, 2006 from UNITED STATES Additional patient health information: Female patient , 38 years of age, . Anafranil dosage: Oral. During the same period patient was treated with OXCARBAZEPINE (Oral) (View Oxcarbazepine Review and Oxcarbazepine Label ), TRAMADOL HCL (Oral) (View Tramadol Hcl Review and Tramadol Hcl Label ).

5216451-1 | Pleural Effusion
Adverse event was reported on Jan 03, 2007 by a Female patient taking Anafranil (View Usage) (Dosage: Unk, Unk, Oral) was diagnosed with depression (What is depression?), pleural effusion, breast cancer (What is breast cancer?), hypertension, pain (What is pain?) and. Location: JAPAN , 60 years of age, weighting 138.5 lb, Patient had the following side effects: pleural effusion. During the same period patient was treated with LASIX (See Image) (View Lasix Review and Lasix Label ), NITRAZEPAM (Unk, Unk, Oral) (View Nitrazepam Review and Nitrazepam Label ), ALMARL(AROTINOLOL HYDROCHLORIDE) (Unk, Unk, Oral) (View Almarl(arotinolol Hydrochloride) Review and Almarl(arotinolol Hydrochloride) Label ), LOXONIN /00890702(LOXOPROFEN SODIUM) (Unk, Unk, Oral) (View Loxonin /00890702(loxoprofen Sodium) Review and Loxonin /00890702(loxoprofen Sodium) Label ). Patient was hospitalized.

5169735-X | C-reactive Protein Increased, Carbohydrate Antigen 15-3 Increased, Confusional State, Disorientation, Echography Abnormal, Electroencephalogram Abnormal, Fall, Hyperthermia, Hypokalaemia
on Nov 29, 2006 Female patient from ITALY , 83 years of age, was diagnosed with depression (What is depression?) and was treated with Anafranil (View Usage). After Anafranil was administered, patient had the following side effects: c-reactive protein increased, carbohydrate antigen 15-3 increased, confusional state, disorientation, echography abnormal, electroencephalogram abnormal, fall (What is fall?), hyperthermia, hypokalaemia. Anafranil dosage: 1 Df/day. During the same period patient was treated with DITROPAN (1 Df/day) (View Ditropan Review and Ditropan Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), FEMARA (1 Df/day) (View Femara Review and Femara Label ), LIPANOR (1 Df/day) (View Lipanor Review and Lipanor Label ), TANAKAN (2 Df/day) (View Tanakan Review and Tanakan Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.

5157195-4 | Folate Deficiency, Hypoalbuminaemia, Hyponatraemia, Hypoproteinaemia, Malnutrition, Pancytopenia
on Nov 13, 2006 Female patient from FRANCE , 78 years of age, was treated with Anafranil (View Usage). Patient experienced the following unwanted or unexpected effects: folate deficiency, hypoalbuminaemia, hyponatraemia, hypoproteinaemia, malnutrition, pancytopenia. Anafranil dosage: . During the same period patient was treated with COAPROVEL (View Coaprovel Review and Coaprovel Label ), KALEORID (View Kaleorid Review and Kaleorid Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), LANZOR (View Lanzor Review and Lanzor Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), VOLTAREN (50 Mg, Unk) (View Voltaren Review and Voltaren Label ). Patient was hospitalized.

4943460-X | Testicular Pain
Patient was taking Anafranil (View Usage). Patient had the following side effects: testicular pain on Mar 13, 2006 from UNITED STATES Additional patient health information: Male patient , 25 years of age, weighting 144.0 lb, was diagnosed with obsessive-compulsive disorder (What is obsessive-compulsive disorder?) and. Anafranil dosage: 25mg One - Two Po Q Hs.

4852456-8 | Coma, Electrocardiogram Qrs Complex Abnormal, Glasgow Coma Scale Abnormal, Intubation, Sinoatrial Block
Adverse event was reported on Nov 22, 2005 by a Female patient taking Anafranil (View Usage) (Dosage: ) . Location: FRANCE , 33 years of age, After Anafranil was administered, patient had the following side effects: coma, electrocardiogram qrs complex abnormal, glasgow coma scale abnormal, intubation, sinoatrial block. During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ), TRANXENE (View Tranxene Review and Tranxene Label ), IMOVANE (View Imovane Review and Imovane Label ), EFFEXOR (View Effexor Review and Effexor Label ), ESCITALOPRAM OXALATE (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ). Patient was hospitalized.

4844483-1 | Coma, Electrocardiogram Qrs Complex Abnormal, Glasgow Coma Scale Abnormal, Intubation, Sinoatrial Block
on Nov 22, 2005 Female patient from FRANCE , 33 years of age, was treated with Anafranil (View Usage). Patient experienced the following unwanted or unexpected effects: coma, electrocardiogram qrs complex abnormal, glasgow coma scale abnormal, intubation, sinoatrial block. Anafranil dosage: . During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ), TRANXENE (View Tranxene Review and Tranxene Label ), IMOVANE (View Imovane Review and Imovane Label ), EFFEXOR (View Effexor Review and Effexor Label ), ESCITALOPRAM OXALATE (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ). Patient was hospitalized.

4809262-X | Apgar Score Low, Caesarean Section, Gastrooesophageal Reflux Disease, Neonatal Disorder, Premature Baby
on Oct 10, 2005 Male patient from UNITED KINGDOM , weighting 3.53 lb, was treated with Anafranil (View Usage). Patient had the following side effects: apgar score low, caesarean section, gastrooesophageal reflux disease, neonatal disorder, premature baby. Anafranil dosage: Transplacental. During the same period patient was treated with LACTULOSE CONCENTRATE (Transplacental) (View Lactulose Concentrate Review and Lactulose Concentrate Label ), AMOXICILLIN (Transplacental) (View Amoxicillin Review and Amoxicillin Label ), SENNA (SENNA, SENNA ALEXANDRINA) (Transplacental) (View Senna (senna, Senna Alexandrina) Review and Senna (senna, Senna Alexandrina) Label ), CYCLIZINE (CYCLIZINE) (Transplacental) (View Cyclizine (cyclizine) Review and Cyclizine (cyclizine) Label ), GAVISCON (Transplacnetal) (View Gaviscon Review and Gaviscon Label ).

4809261-8 | Apgar Score Low, Caesarean Section, Jaundice Neonatal, Premature Baby
Patient was taking Anafranil (View Usage). After Anafranil was administered, patient had the following side effects: apgar score low, caesarean section, jaundice neonatal, premature baby on Oct 10, 2005 from UNITED KINGDOM Additional patient health information: Female patient , weighting 3.53 lb, . Anafranil dosage: Transplacental. During the same period patient was treated with LACTULOSE (Transplacental) (View Lactulose Review and Lactulose Label ), AMOXICILLIN (Transplacental) (View Amoxicillin Review and Amoxicillin Label ), SENNA(SENNA, SENNA ALEXANDRINA) (Transplacental) (View Senna(senna, Senna Alexandrina) Review and Senna(senna, Senna Alexandrina) Label ), CYCLIZINE (CYCLIZINE) (Transplacental) (View Cyclizine (cyclizine) Review and Cyclizine (cyclizine) Label ), GAVISCON (Transplacental) (View Gaviscon Review and Gaviscon Label ).

4776048-4 | Hyperhidrosis, Serotonin Syndrome, Tremor
Adverse event was reported on Aug 18, 2005 by a Female patient taking Anafranil (View Usage) (Dosage: 150 Mg/d) was diagnosed with major depression and. Location: JAPAN , 73 years of age, Patient experienced the following unwanted or unexpected effects: hyperhidrosis, serotonin syndrome, tremor. During the same period patient was treated with RITALIN (20 Mg/d) (View Ritalin Review and Ritalin Label ).

4776047-2 | Hyperhidrosis, Serotonin Syndrome, Tremor
on Aug 18, 2005 Female patient from JAPAN , 73 years of age, was diagnosed with major depression and was treated with Anafranil (View Usage). Patient had the following side effects: hyperhidrosis, serotonin syndrome, tremor. Anafranil dosage: 150 Mg/d. During the same period patient was treated with RITALIN (20 Mg/d) (View Ritalin Review and Ritalin Label ).

4714888-8 | Anuria, Blood Creatine Phosphokinase Increased, Delirium, Depressed Level Of Consciousness, Disorientation, Hallucination, Visual, Neuroleptic Malignant Syndrome, Phonological Disorder, Salivary Hypersecretion
on May 21, 2003 Female patient from JAPAN , 87 years of age, was diagnosed with major depression and was treated with Anafranil (View Usage). After Anafranil was administered, patient had the following side effects: anuria, blood creatine phosphokinase increased, delirium, depressed level of consciousness, disorientation, hallucination, visual, neuroleptic malignant syndrome, phonological disorder, salivary hypersecretion. Anafranil dosage: 75 Mg/day. During the same period patient was treated with DRAGANON (600 Mg/day) (View Draganon Review and Draganon Label ), GRAMALIL (150 Mg/day) (View Gramalil Review and Gramalil Label ). Patient was hospitalized.

4700376-1 | Anxiety
Patient was taking Anafranil (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?) on Feb 09, 2005 from Additional patient health information: Male patient , weighting 100.0 lb, . Anafranil dosage: .

4678199-1 | Blood Alkaline Phosphatase Increased, Blood Pressure Decreased, Depressed Level Of Consciousness, Prothrombin Time Prolonged, Suicide Attempt, Therapeutic Agent Toxicity
Adverse event was reported on May 19, 2005 by a Female patient taking Anafranil (View Usage) (Dosage: 250mg, One Time) was diagnosed with overdose and. Location: , 39 years of age, Patient had the following side effects: blood alkaline phosphatase increased, blood pressure decreased, depressed level of consciousness, prothrombin time prolonged, suicide attempt, therapeutic agent toxicity. During the same period patient was treated with SILECE (60mg, One Time Dose) (View Silece Review and Silece Label ), LENDORM (22 Tablets, One Time Dose) (View Lendorm Review and Lendorm Label ), CERCINE (50mg, One Time Dose) (View Cercine Review and Cercine Label ), CONTOMIN (CHLORPROMAZINE HCL) (View Contomin (chlorpromazine Hcl) Review and Contomin (chlorpromazine Hcl) Label ), LEXOTAN (View Lexotan Review and Lexotan Label ), PURSENNID (View Pursennid Review and Pursennid Label ). Patient was hospitalized.

4678197-8 | Asterixis, Cerebral Infarction, Depressed Level Of Consciousness, Dizziness, Fall, Speech Disorder
on May 19, 2005 Male patient from , 62 years of age, was diagnosed with depression (What is depression?), convulsion and was treated with Anafranil (View Usage). After Anafranil was administered, patient had the following side effects: asterixis, cerebral infarction, depressed level of consciousness, dizziness (What is dizziness?), fall (What is fall?), speech disorder. Anafranil dosage: 160mg, Daily. During the same period patient was treated with TEGRETOL, STRENGTH NOT PROVIDED (800mg, Daily) (View Tegretol, Strength Not Provided Review and Tegretol, Strength Not Provided Label ), LEXOTAN (View Lexotan Review and Lexotan Label ). Patient was hospitalized.

4678196-6 | Iron Deficiency Anaemia, Microcytic Anaemia, Pneumonitis
on May 16, 2005 Female patient from , 61 years of age, was treated with Anafranil (View Usage). Patient experienced the following unwanted or unexpected effects: iron deficiency anaemia, microcytic anaemia, pneumonitis. Anafranil dosage: 25mg, Qid. Patient was hospitalized.

4664986-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Creatine Phosphokinase Increased, Blood Creatinine Increased, Blood Urea Increased, Convulsion, Depressed Level Of Consciousness, Multi-organ Failure
Patient was taking Anafranil (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, blood creatinine increased, blood urea increased, convulsion, depressed level of consciousness, multi-organ failure on May 03, 2005 from Additional patient health information: Female patient , 87 years of age, was diagnosed with depression (What is depression?), anorexia and. Anafranil dosage: 25 Mg, Qd, Iv. During the same period patient was treated with GASTER (View Gaster Review and Gaster Label ), MAXIPIME (View Maxipime Review and Maxipime Label ).

4662137-1 | Anxiety, Appetite Disorder, Asthenia, Dehydroepiandrosterone Increased, Dizziness, Hirsutism, Hyperphagia, Hypothalamo-pituitary Disorders
Adverse event was reported on Apr 28, 2005 by a Female patient taking Anafranil (View Usage) (Dosage: 25-37.5 Mg, Q D, Po) was diagnosed with obsessive-compulsive disorder (What is obsessive-compulsive disorder?) and. Location: , 36 years of age, After Anafranil was administered, patient had the following side effects: anxiety (What is anxiety?), appetite disorder, asthenia, dehydroepiandrosterone increased, dizziness (What is dizziness?), hirsutism, hyperphagia, hypothalamo-pituitary disorders. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), TRAZODONE (View Trazodone Review and Trazodone Label ), AMYTRIPTYLINE (View Amytriptyline Review and Amytriptyline Label ). Patient was hospitalized and became disabled.

4647524-X | Multi-organ Failure, Neuroleptic Malignant Syndrome
on Apr 11, 2005 Female patient from , 87 years of age, was diagnosed with anorexia, depression (What is depression?) and was treated with Anafranil (View Usage). Patient experienced the following unwanted or unexpected effects: multi-organ failure, neuroleptic malignant syndrome. Anafranil dosage: 25 Mg. During the same period patient was treated with GASTER (View Gaster Review and Gaster Label ), MAXIPIME (View Maxipime Review and Maxipime Label ).

4646742-4 | Coma, Decubitus Ulcer, Ileus, Intentional Misuse, Intestinal Obstruction, Mass, Pneumonia Aspiration, Refusal Of Treatment By Patient
on Apr 15, 2005 Female patient from , 31 years of age, was diagnosed with overdose and was treated with Anafranil (View Usage). Patient had the following side effects: coma, decubitus ulcer, ileus, intentional misuse, intestinal obstruction, mass, pneumonia aspiration, refusal of treatment by patient. Anafranil dosage: 1400 Mg One Time. During the same period patient was treated with PHENOBARBITAL TAB (6660 Mg One Time) (View Phenobarbital Tab Review and Phenobarbital Tab Label ), CHLORPROMAZINE (3975 Mg) (View Chlorpromazine Review and Chlorpromazine Label ). Patient was hospitalized.

4646729-1 | Neuroleptic Malignant Syndrome
Patient was taking Anafranil (View Usage). After Anafranil was administered, patient had the following side effects: neuroleptic malignant syndrome on Apr 12, 2005 from Additional patient health information: Female patient , 68 years of age, . Anafranil dosage: .

4641747-1 | Blood Chloride Decreased, Blood Uric Acid Decreased, Chills, Dizziness, Inappropriate Antidiuretic Hormone Secretion, Mental Impairment, Tremor
Adverse event was reported on Apr 06, 2005 by a Female patient taking Anafranil (View Usage) (Dosage: 75 Mg Qd, Po) was diagnosed with depression (What is depression?) and. Location: , 65 years of age, Patient experienced the following unwanted or unexpected effects: blood chloride decreased, blood uric acid decreased, chills, dizziness (What is dizziness?), inappropriate antidiuretic hormone secretion, mental impairment, tremor. During the same period patient was treated with FERO GRADUMET (View Fero-gradumet Review and Fero-gradumet Label ), LIMETHASONE (View Limethasone Review and Limethasone Label ), LOXONIN (View Loxonin Review and Loxonin Label ), LUDIOMIL (View Ludiomil Review and Ludiomil Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), RIDAURA (View Ridaura Review and Ridaura Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ), SELBEX (View Selbex Review and Selbex Label ). Patient was hospitalized.

4641744-6 | Cardiomyopathy, Conjunctival Hyperaemia, Excoriation, Hyperthermia, Neuroleptic Malignant Syndrome, Petechiae, Serotonin Syndrome, Tryptase Increased
on Apr 05, 2005 Female patient from , 65 years of age, weighting 82.00 lb, was treated with Anafranil (View Usage). Patient had the following side effects: cardiomyopathy (What is cardiomyopathy?), conjunctival hyperaemia, excoriation, hyperthermia, neuroleptic malignant syndrome, petechiae, serotonin syndrome, tryptase increased. Anafranil dosage: Antidepressant. During the same period patient was treated with FLUVOXAMINE (View Fluvoxamine Review and Fluvoxamine Label ), LITHIUM (View Lithium Review and Lithium Label ), LEVOMEPROMAZINE (View Levomepromazine Review and Levomepromazine Label ).

4639173-4 | Asthenia, Neuroleptic Malignant Syndrome, Overdose
on Apr 05, 2005 Female patient from , 52 years of age, was diagnosed with insomnia and was treated with Anafranil (View Usage). After Anafranil was administered, patient had the following side effects: asthenia, neuroleptic malignant syndrome, overdose. Anafranil dosage: One Time. During the same period patient was treated with SILECE (View Silece Review and Silece Label ), PICOBEN (View Picoben Review and Picoben Label ), VEGETAMIN B (View Vegetamin B Review and Vegetamin B Label ), ALINAMIN F (View Alinamin F Review and Alinamin F Label ), CINAL (View Cinal Review and Cinal Label ), TALION (View Talion Review and Talion Label ). Patient was hospitalized.

4618263-6 | Confusional State, Inappropriate Antidiuretic Hormone Secretion, Major Depression, Mutism
Patient was taking Anafranil (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, inappropriate antidiuretic hormone secretion, major depression, mutism on Mar 11, 2005 from Additional patient health information: Male patient , 73 years of age, was diagnosed with depression (What is depression?) and. Anafranil dosage: 125 Mg, Qd. During the same period patient was treated with FLECAINE (View Flecaine Review and Flecaine Label ), FORLAX (View Forlax Review and Forlax Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), SOLIAN (View Solian Review and Solian Label ), ZESTRIL (View Zestril Review and Zestril Label ). Patient was hospitalized.

4613162-8 | Anxiety, Depression, Dizziness, Dry Mouth, Fatigue, Hyperhidrosis, Nightmare, Urinary Tract Disorder
Adverse event was reported on Mar 04, 2005 by a Male patient taking Anafranil (View Usage) (Dosage: 25 Mg, Q D) was diagnosed with anxiety (What is anxiety?) and. Location: , 65 years of age, Patient had the following side effects: anxiety (What is anxiety?), depression (What is depression?), dizziness (What is dizziness?), dry mouth, fatigue, hyperhidrosis, nightmare, urinary tract disorder. During the same period patient was treated with ATACAND (View Atacand Review and Atacand Label ).

4594813-3 | Blood Growth Hormone Increased, Blood Prolactin Increased, Blood Testosterone Increased, Laboratory Test Abnormal, Testicular Disorder
on Feb 08, 2005 Male patient from , 17 years of age, was treated with Anafranil (View Usage). After Anafranil was administered, patient had the following side effects: blood growth hormone increased, blood prolactin increased, blood testosterone increased, laboratory test abnormal, testicular disorder (What is testicular disorder?). Anafranil dosage: . Patient was hospitalized.

4584720-4 | Blood Pressure Systolic Decreased, Depressed Level Of Consciousness, Haemodialysis, Heart Rate Decreased, Heart Rate Increased, Hypotension, Intentional Misuse, Overdose, Restlessness
on Jan 15, 2004 Male patient from , 25 years of age, weighting 154.3 lb, was diagnosed with depression (What is depression?), major depression and was treated with Anafranil (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure systolic decreased, depressed level of consciousness, haemodialysis, heart rate decreased, heart rate increased, hypotension, intentional misuse, overdose, restlessness. Anafranil dosage: 75 Mg/d. During the same period patient was treated with LUDIOMIL (75 Mg/d) (View Ludiomil Review and Ludiomil Label ), AMOXAPINE (Unk, Unk) (View Amoxapine Review and Amoxapine Label ), ROHYPNOL (1 Mg, Qd) (View Rohypnol Review and Rohypnol Label ), ETIZOLAM (.5 Mg, Qd) (View Etizolam Review and Etizolam Label ). Patient was hospitalized and became disabled.

4573046-0 | Agitation, Anxiety, Body Temperature Increased, Confusional State, Hyperhidrosis, Hyperthermia Malignant, Hypotonia, Myoclonus, Tremor
Patient was taking Anafranil (View Usage). Patient had the following side effects: agitation, anxiety (What is anxiety?), body temperature increased, confusional state, hyperhidrosis, hyperthermia malignant, hypotonia, myoclonus, tremor on Jan 20, 2005 from Additional patient health information: Female patient , 78 years of age, was diagnosed with depression (What is depression?) and. Anafranil dosage: 125 Mg Qd. During the same period patient was treated with THERALENE (View Theralene Review and Theralene Label ), FLECAINE (View Flecaine Review and Flecaine Label ), NICARDIPINE HCL (View Nicardipine Hcl Review and Nicardipine Hcl Label ).

4572267-0 | Blood Pressure Decreased, Brain Oedema, Convulsion, Disseminated Intravascular Coagulation, Gastrointestinal Haemorrhage, Heat Stroke, Loss Of Consciousness, Multi-organ Failure, Muscle Spasms
Adverse event was reported on Jan 19, 2005 by a Male patient taking Anafranil (View Usage) (Dosage: 225 Mg, Qd) was diagnosed with depression (What is depression?) and. Location: , 16 years of age, After Anafranil was administered, patient had the following side effects: blood pressure decreased, brain oedema, convulsion, disseminated intravascular coagulation, gastrointestinal haemorrhage, heat stroke, loss of consciousness, multi-organ failure, muscle spasms. During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), TRICYCLIC ANTIDEPRESSANT (View Tricyclic Antidepressant Review and Tricyclic Antidepressant Label ).

4554130-4 | Neuroleptic Malignant Syndrome
on Jan 07, 2005 Male patient from , 67 years of age, was treated with Anafranil (View Usage). Patient experienced the following unwanted or unexpected effects: neuroleptic malignant syndrome. Anafranil dosage: . During the same period patient was treated with TOFRANIL (View Tofranil Review and Tofranil Label ).